Fauvet Girel
FAUV.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.12M
Close$
Share Statistics
| Market cap | $6.12 Million |
|---|---|
| Enterprise Value | $3.46 Million |
| Dividend Yield | $18.50 (4.78%) |
| Earnings per Share | $-0.56 |
| Beta | 0.38 |
| Outstanding Shares | 250,810 |
Return
| Return on Equity | 13.86% |
|---|---|
| Return on Assets | 13.38% |
| Return on Invested Capital | 18.43% |
Valuation & Multiples
| P/E Ratio | -4.11 |
|---|---|
| PEG | 3.97 |
| Price to Sales | - |
| Price to Book Ratio | 2.44 |
| Enterprise Value to Revenue | 40.26 |
| Enterprise Value to EBIT | 7.16 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ABL Diagnostics Société anonyme
22 employees
CEO: Jean-Claude Bourcet ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. The co...